Nutralife Biosciences Inc (NLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12 | 17 | 25 | 63 | 145 |
| Receivables | N/A | 0 | 2 | 35 | 2 |
| Inventories | 94 | 97 | 70 | 275 | 21 |
| TOTAL | $259 | $385 | $97 | $373 | $168 |
| Non-Current Assets | |||||
| PPE Net | 194 | 238 | 249 | 274 | 81 |
| TOTAL | $194 | $238 | $249 | $274 | $81 |
| Total Assets | $453 | $623 | $346 | $648 | $249 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,342 | 1,111 | 828 | 473 | 360 |
| Accounts payable and accrued liabilities | 19 | 33 | 34 | 110 | 52 |
| Accrued Expenses | 725 | 470 | 236 | 41 | 4 |
| Other current liabilities | 35 | 35 | N/A | N/A | N/A |
| TOTAL | $2,553 | $2,157 | $1,295 | $719 | $416 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,553 | $2,157 | $1,295 | $719 | $416 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,142 | 3,107 | 22,282 | N/A | N/A |
| Common Shares | 5 | 3 | 2 | 2 | 2 |
| Retained earnings | -9,130 | -7,031 | -4,857 | -2,781 | -697 |
| TOTAL | $-2,101 | $-1,533 | $-949 | $-71 | $-167 |
| Total Liabilities And Equity | $453 | $623 | $346 | $648 | $249 |